64 related articles for article (PubMed ID: 19272636)
1. Interleukin-10 correlates with oxidized low density lipoprotein in coronary culprit plaques.
Nishihira K; Imamura T; Ishikawa T; Yamashita A; Shibata Y; Itabe H; Kitamura K; Asada Y
Thromb Res; 2009 Jul; 124(3):335-7. PubMed ID: 19272636
[No Abstract] [Full Text] [Related]
2. Interleukin-10 expression is positively correlated with oxidized LDL deposition and inversely with T-lymphocyte infiltration in atherosclerotic intimas of human coronary arteries.
Sumiyoshi S; Nakashima Y; Chen YX; Itabe H; Sueishi K
Pathol Res Pract; 2006; 202(3):141-50. PubMed ID: 16460885
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus and coronary artery disease in heart transplant patients--accelerated low density lipoprotein and lipoprotein(a) modification as a proposed factor.
Fay L
J Heart Lung Transplant; 1993; 12(1 Pt 1):155. PubMed ID: 8382950
[No Abstract] [Full Text] [Related]
4. Oxidised low density lipoprotein, antioxidants and coronary atherosclerosis.
Gambhir DS; Gambhir JK
Indian Heart J; 1997; 49(1):19-22. PubMed ID: 9130420
[No Abstract] [Full Text] [Related]
5. Identification of atherosclerotic lesion-prone sites through patient-specific simulation of low-density lipoprotein accumulation.
Olgac U; Kurtcuoglu V; Saur SC; Poulikakos D
Med Image Comput Comput Assist Interv; 2008; 11(Pt 2):774-81. PubMed ID: 18982675
[TBL] [Abstract][Full Text] [Related]
6. Hydrolytic enzymes released from resident macrophages and located in the intima extracellular matrix as agents that modify retained apolipoprotein B lipoproteins.
Camejo G
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1312-3. PubMed ID: 12909567
[No Abstract] [Full Text] [Related]
7. [Lipoproteins, antioxidants, and coronary cardiopathy].
Guimarães AC
Arq Bras Cardiol; 1995 Sep; 65(3):289-95. PubMed ID: 8579520
[No Abstract] [Full Text] [Related]
8. Associations of lipoprotein lipase S447X and apolipoprotein E genotypes with low-density lipoprotein subfractions in Turkish patients with coronary artery disease.
Aydogan HY; Isbir S; Kurnaz O; Gormus U; Isbir T
In Vivo; 2009; 23(1):155-61. PubMed ID: 19368142
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein accumulation in aortic and coronary artery walls.
Scott PJ; Hurley PJ
Isr J Med Sci; 1969; 5(4):631-4. PubMed ID: 4980550
[No Abstract] [Full Text] [Related]
10. Prevention.
Forrester JS
Curr Opin Cardiol; 2000 Sep; 15(5):343-7. PubMed ID: 11128187
[No Abstract] [Full Text] [Related]
11. Uptake of oxidized LDL by human atherosclerotic plaque.
Iuliano L; Signore A; Violi F
Circulation; 1997 Sep; 96(6):2093-4. PubMed ID: 9323116
[No Abstract] [Full Text] [Related]
12. Low-density lipoprotein oxidation and coronary atherosclerosis.
Ziedén B; Molgaard J; Olsson AG
Lancet; 1992 Sep; 340(8821):727-8. PubMed ID: 1355822
[No Abstract] [Full Text] [Related]
13. Oxidized low-density lipoprotein is not equal to oxidative stress.
van Tits LJ; Stalenhoef AF
Am J Cardiol; 2008 Oct; 102(8):1118. PubMed ID: 18929727
[No Abstract] [Full Text] [Related]
14. The effects of lifestyle modification on a new oxidized low-density lipoprotein marker, serum amyloid A-LDL, in subjects with primary lipid disorder.
Kotani K; Koibuchi H; Yamada T; Taniguchi N
Clin Chim Acta; 2009 Nov; 409(1-2):67-9. PubMed ID: 19723514
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to oxidized low density lipoprotein in relation with coronary artery disease.
Soto Y; Conde H; Aroche R; Brito V; Luaces P; Nasiff A; Obregón A; Vázquez López AM
Hum Antibodies; 2009; 18(3):109-17. PubMed ID: 19729805
[TBL] [Abstract][Full Text] [Related]
16. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
[TBL] [Abstract][Full Text] [Related]
17. The best "model system" for human (coronary arteries) is human.
Braun OO; Insel PA
J Am Coll Cardiol; 2009 Sep; 54(13):1146-8. PubMed ID: 19761934
[No Abstract] [Full Text] [Related]
18. Serial changes in oxidized low-density lipoprotein associated with culprit vessel in ST-elevation myocardial infarction--a promising marker?
Napoleão P; Selas M; Toste A; Turkman A; Andreozzi V; Viegas-Crespo AM; Pinheiro T; Ferreira RC
Rev Port Cardiol; 2009 Mar; 28(3):303-8. PubMed ID: 19480313
[TBL] [Abstract][Full Text] [Related]
19. Coronary artery disease with normal lipids and low coronary artery calcium in two women with high lipoprotein(a).
Haxhi J; Pershwitz G; Thompson PD
J Clin Lipidol; 2020; 14(2):186-188. PubMed ID: 31983675
[TBL] [Abstract][Full Text] [Related]
20. Effects of hypertension and hypercholesteremia on the permeability of fibrinogen and low density lipoprotein in the coronary artery of rabbits. Immunoelectron-microscopic study.
Kurozumi T; Imamura T; Tanaka K; Yae Y; Koga S
Atherosclerosis; 1983 Dec; 49(3):267-76. PubMed ID: 6661269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
